A comparative study of CIDP in a cohort of HIV-infected and HIV-uninfected patients
Citation Manager Formats
Make Comment
See Comments

Article Information
- Received September 9, 2016
- Accepted in final form October 21, 2016
- First Published December 15, 2016.
Author Disclosures
- Kaminie Moodley, FCN,
- Pierre L.A. Bill, FCN and
- Vinod Bhagu Patel, PhD
- Kaminie Moodley, FCN,
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Pierre L.A. Bill, FCN and
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Vinod Bhagu Patel, PhD
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
NONE
- Correspondence to Dr. Patel: patelv{at}ukzn.ac.za or K. Moodley: Kaminie{at}live.co.za
Article usage
Cited By...
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Sevil Yaşar and Dr. Behnam Sabayan
► Watch
Topics Discussed
Alert Me
Recommended articles
-
Articles
Dispersion of the distal compound muscle action potential as a diagnostic criterion for chronic inflammatory demyelinating polyneuropathyPariwat Thaisetthawatkul, Eric L. Logigian, David N. Herrmann et al.Neurology, November 26, 2002 -
Articles
PML-IRIS in patients with HIV infectionClinical manifestations and treatment with steroidsK. Tan, R. Roda, L. Ostrow et al.Neurology, January 07, 2009 -
Views & Reviews
Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathyB. Tackenberg, J. D. Lünemann, A. Steinbrecher et al.Neurology, May 07, 2007 -
Article
Chronic inflammatory demyelinating polyneuropathyClinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathyKenneth C. Gorson, Gregory Allam, Allan H. Ropper et al.Neurology, February 01, 1997